A 63-year-old Vietnamese-speaking man with a history of scleritis in the left eye, epiretinal membrane, dry eye syndrome and age-related cataracts presented to the retina clinic for a follow-up on a chronic blind, painful left eye.The patient had a lon…
Eye care practitioners have a wealth of new information to inform their handling of dry eye disease with the third iteration of the Tear Film & Ocular Surface Society Dry Eye Workshop report.“Everybody does dry eye differently,” Fiona Stapleton, FCOpto…
AVD-104 yielded sustained vision improvements in patients with geographic atrophy, with no statistical difference reported in the rate of change in GA area vs. monthly avacincaptad pegol, according to a press release.The phase 2a SIGLEC trial randomly …
ORLANDO — In this video, Jay S. Duker, MD, president and CEO of EyePoint Pharmaceuticals, discusses preclinical data on vorolanib presented at Eyecelerator@AAO.“We’ve always known that vorolanib was a potent inhibitor of all the VEGF receptors,” Duker …
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Stephen J. Kim, MD, discusses the controversy surrounding FDA-approved treatments for geographic atrophy.Two treatments are commercially available, but Kim, professor of ophtha…
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Stephen J. Kim, MD, discusses GLP-1 drugs and their retinal side effects.GLP-1s can cause rapid progression of diabetic retinopathy, Kim said, and there are increasing concerns…